UnitedHealth Group stock gains on Q2 beat and raised 2026 guidance
Published on 09/19/2026 at 12:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UnitedHealth Group stock (ISIN US91324P1021) ended the last completed trading day on September 18, 2026 at USD 377.06 on the New York Stock Exchange, around 14.2% above its level at the beginning of 2026 and reflecting a solid recovery phase for the health insurer.
Stock performance and current valuation
According to MarketBeat data, UnitedHealth Group shares closed at USD 377.06 on September 18, 2026 on the New York Stock Exchange, up USD 1.85 or 0.49% from the prior close, with an after-hours indication of USD 377.15 as of 7:58 p.m. Eastern Time the same day.
The same overview shows that UnitedHealth Group stock started the year at USD 330.32 and has since gained 14.2%, underscoring how the recovery in 2026 has translated into a meaningful year-to-date performance for long-term investors.
On September 18, 2026, a German-language intraday report from finanzen.ch noted UnitedHealth Group trading at USD 375.28 at 4:28 p.m. local New York time, with an intraday high of USD 376.82 and a low of USD 372.50, highlighting relatively contained volatility within a narrow range on that trading day.
Recent earnings and guidance upgrades
A key driver behind the improved sentiment on UnitedHealth Group stock has been the company’s recent earnings delivery and updated outlook. One analysis of the second quarter of 2026 reported that UnitedHealth Group delivered strong Q2 results, beating expectations on both revenue and earnings per share and raising its full-year 2026 guidance, while keeping its medical loss ratio at 86.7%.
In addition, consensus commentary cited in that analysis highlighted that analysts had increased their earnings estimates for UnitedHealth Group for the coming quarters, with no downgrades, supporting the view that the company’s operational trends are improving alongside its financial performance.
Earlier in the year, UnitedHealth Group outlined its first-quarter 2026 performance in detail. In the Q1 2026 earnings materials, management reported adjusted earnings per share of USD 7.23, which was described as well ahead of internal expectations, and total revenue of USD 111.7 billion for the quarter, representing 2% growth year over year.
The same Q1 2026 commentary indicated that operating cash flows reached USD 8.9 billion in that quarter, equivalent to approximately 1.4 times net income, providing a solid cash backing to the reported earnings and suggesting that the strong result was not merely accounting-driven.
For investors, the combination of Q2 2026 beats on revenue and EPS, a raised full-year 2026 guidance and the earlier Q1 2026 evidence of cash-flow strength provides a coherent narrative of recovery in core operations, particularly in Medicare and Optum Health, which had been highlighted as areas of strength.
Analyst estimates and sector context
UnitedHealth Group’s earnings trajectory is also reflected in recent consensus estimates for the coming years. A healthcare-focused article discussed that the consensus earnings per share estimates for UnitedHealth Group stand at USD 19.82 for 2026 and USD 22.54 for 2027, implying forecast EPS growth of 21.2% between 2025 and 2026 and a further 13.7% between 2026 and 2027, based on the underlying assumptions.
The same report underlined that these EPS estimates had seen six upward revisions in the past 60 days without any downward changes, and that UnitedHealth Group had surpassed earnings expectations in each of the past four quarters with an average surprise of 12.1%, reinforcing the picture of a company consistently delivering above-consensus results.
Separately, a Zacks Analyst Blog post highlighted UnitedHealth Group as one of three fresh large-cap stocks with a Zacks Rank of number 1, or Strong Buy, within the medical HMOs industry, noting that the stock was trading at about USD 379 with a market capitalization of approximately USD 348.5 billion and a forward 12-month price-to-earnings ratio of 19.6, indicating a valuation that balances growth expectations with the defensive nature of the business model.
The sector backdrop also matters: an article on employer health costs pointed out that UnitedHealth Group has been expanding its presence in the individual coverage health reimbursement arrangement market by more than quadrupling its off-exchange offerings in 2026 and entering 20 additional states, a move that may support future enrollment and revenue growth.
Dividend, upcoming earnings date and investor takeaways
Dividend and event data from MarketBeat show that UnitedHealth Group has a dividend payable on September 22, 2026, with the ex-dividend date on September 14, 2026, in line with the company’s practice of offering a regular cash return component alongside potential capital gains.
The same source lists the next confirmed earnings date for UnitedHealth Group as October 13, 2026, which will be closely watched by investors as the next checkpoint to validate whether the raised 2026 guidance and the strong first-half performance are being sustained in the second half of the year.
For shareholders, the picture as of September 19, 2026 is one of a stock trading modestly above its early-year level, supported by recent earnings beats, upward revisions to consensus EPS, and an ongoing expansion in specific growth markets such as off-exchange individual plans tied to employer reimbursements.
UnitedHealth Group stock price as of the last trading day
As of the close of trading on September 18, 2026, UnitedHealth Group stock stood at USD 377.06 on the New York Stock Exchange, with an after-hours indication of USD 377.15 later that evening, providing the reference level for investors assessing the stock’s valuation against its recent fundamental progress.
Key data on UnitedHealth Group stock
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Trading venue: New York Stock Exchange
- Price (as of September 18, 2026, 03:59): 377.06 USD
- Market capitalization: 348.50 billion USD (as of September 19, 2026)
- Sector / Industry: Health Care / Managed Health Care
- Index membership: Dow Jones Industrial Average, S&P 500
- Next earnings date: October 13, 2026
